Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases.
Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to assess a patient’s probability of sepsis. The test is designed to simply and clearly determine probability of sepsis using a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Visit our website to learn more: www.cytovale.com